BioCentury
ARTICLE | Financial News

WuXi AppTec prices Hong Kong offering in stormy market

December 7, 2018 10:02 PM UTC

Despite global trade headwinds and a choppy market for biopharma stocks in China, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) managed to price its Hong Kong listing within its proposed range Friday, potentially raising HK$7.9 billion ($1 billion) based on its proposed number of shares. The listing is the third for a unit of New WuXi Life Science Ltd. since a 2016 deal that took the parent company private.

WuXi AppTec priced the offering at HK$68, near the middle of its proposed range of HK$64.10-HK$71.50. The company is to announce the actual number of shares sold on Dec. 12...